β¨ Medicines Distribution Consent
19 FEBRUARY 2009 NEW ZEALAND GAZETTE, No. 20 469
Product: Xigris
Active Ingredient: Drotrecogin alfa (activated) 5mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America
Dated this 12th day of February 2009.
STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1421
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Concerta Extended Release Tablets
Active Ingredient: Methylphenidate hydrochloride 18mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, California, United States of America
Product: Concerta Extended Release Tablets
Active Ingredient: Methylphenidate hydrochloride 27mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, California, United States of America
Product: Concerta Extended Release Tablets
Active Ingredient: Methylphenidate hydrochloride 36mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, California, United States of America
Product: Concerta Extended Release Tablets
Active Ingredient: Methylphenidate hydrochloride 54mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, California, United States of America
Dated this 12th day of February 2009.
STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1422
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg equivalent to imatinib base 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This renewed consent is valid for two years from 14 April 2009.
Product: Glivec
Active Ingredient: Imatinib mesilate 478mg equivalent to imatinib base 400mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This renewed consent is valid for two years from 14 April 2009.
Dated this 12th day of February 2009.
STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1423
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare12 February 2009
Medicines Act 1981, New Medicines, Distribution Consent, Xigris
- STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare12 February 2009
Medicines Act 1981, Changed Medicine, Distribution Consent, Concerta Extended Release Tablets
- STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Renewal of Provisional Consent to the Distribution of a Medicine
π₯ Health & Social Welfare12 February 2009
Medicines Act 1981, Provisional Consent, Renewal, Glivec
- STEWART JESSAMINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
NZ Gazette 2009, No 20